help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licinio, J.
Right arrow Articles by Gold, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licinio, J.
Right arrow Articles by Gold, P. W.

Endocrinology, Vol 129, 562-564, Copyright © 1991 by Endocrine Society


ARTICLES

Localization of interleukin-1 receptor antagonist mRNA in rat brain

J Licinio, ML Wong and PW Gold
Department of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516.

Interleukin-1 (IL-1) is an inflammatory peptide hormone, with potent neuroendocrine effects. IL-1 stimulates the central nervous system production of corticotropin-releasing hormone (CRH), growth hormone (GH), thyroid-stimulating hormone (TSH), and somatostatin, and inhibits the secretion of prolactin and luteinizing hormone (LH). Interleukin-1 receptor antagonist (IL-1ra) is a novel cytokine, recently purified, characterized, and cloned. IL-1ra is a pure endogenous antagonist of IL- 1:IL-1 function is modulated not only by local levels of IL-1, but also by the levels of IL-1ra. We have localized by in situ hybridization histochemistry IL-1ra mRNA in rat brain, in areas of importance to neuroendocrine function, such as the paraventricular nucleus (PVN) of the hypothalamus, hippocampus, as well as cerebellum. These findings indicate that IL-1ra is produced in brain in areas of relevance to the regulation of neuroendocrine function and suggest that IL-1ra may modulate the neuroendocrine effects of IL-1.


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E Tarkowski, N Andreasen, A Tarkowski, and K Blennow
Intrathecal inflammation precedes development of Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1200 - 1205.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Kirkwood, C. Bender, S. Agarwala, A. Tarhini, J. Shipe-Spotloe, B. Smelko, S. Donnelly, and L. Stover
Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy
J. Clin. Oncol., September 1, 2002; 20(17): 3703 - 3718.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Tarkowski, A.-M. Liljeroth, A. Nilsson, A. Ricksten, P. Davidsson, L. Minthon, and K. Blennow
TNF gene polymorphism and its relation to intracerebral production of TNF{alpha} and TNF{beta} in AD
Neurology, June 13, 2000; 54(11): 2077 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, P. B. Bongiorno, V. Rettori, S. M. McCann, and J. Licinio
Interleukin (IL) 1beta , IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
PNAS, January 7, 1997; 94(1): 227 - 232.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
X. Wang, F. C. Barone, N. V. Aiyar, G. Z. Feuerstein, and G. J. del Zoppo
Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats
Stroke, January 1, 1997; 28(1): 155 - 162.
[Abstract] [Full Text]


Home page
StrokeHome page
Y. Yamasaki, Y. Matsuo, N. Matsuura, H. Onodera, Y. Itoyama, and K. Kogure
Transient Increase of Cytokine-Induced Neutrophil Chemoattractant, a Member of the Interleukin-8 Family, in Ischemic Brain Areas After Focal Ischemia in Rats
Stroke, February 1, 1995; 26(2): 318 - 323.
[Abstract] [Full Text]


Home page
NEJMHome page
S. Reichlin
Neuroendocrine-Immune Interactions
N. Engl. J. Med., October 21, 1993; 329(17): 1246 - 1253.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society